Protein‐misfolding diseases and chaperone‐based therapeutic approaches
TK Chaudhuri, S Paul - The FEBS journal, 2006 - Wiley Online Library
A large number of neurodegenerative diseases in humans result from protein misfolding and
aggregation. Protein misfolding is believed to be the primary cause of Alzheimer's disease …
aggregation. Protein misfolding is believed to be the primary cause of Alzheimer's disease …
Folding and stability of α-helical integral membrane proteins
KR MacKenzie - Chemical reviews, 2006 - ACS Publications
Integral membrane proteins are embedded in a watersolvated lipid bilayer that presents
contrasting features in an anisotropic, chemically heterogeneous environment. A …
contrasting features in an anisotropic, chemically heterogeneous environment. A …
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor, KS Straley, D Cao… - … of Physiology-Lung …, 2006 - journals.physiology.org
Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in cftr, a gene encoding a
PKA-regulated Cl− channel. The most common mutation results in a deletion of …
PKA-regulated Cl− channel. The most common mutation results in a deletion of …
Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16
PJ Kausalya, S Amasheh, D Günzel… - The Journal of …, 2006 - Am Soc Clin Investig
Claudin-16 (Cldn16) is selectively expressed at tight junctions (TJs) of renal epithelial cells
of the thick ascending limb of Henle's loop, where it plays a central role in the reabsorption …
of the thick ascending limb of Henle's loop, where it plays a central role in the reabsorption …
Suppressive effects of 4‐phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress
K Kubota, Y Niinuma, M Kaneko… - Journal of …, 2006 - Wiley Online Library
Endoplasmic reticulum (ER) stress is defined as an accumulation of unfolded proteins in the
endoplasmic reticulum. 4‐phenylbutyrate (4‐PBA) has been demonstrated to promote the …
endoplasmic reticulum. 4‐phenylbutyrate (4‐PBA) has been demonstrated to promote the …
Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs
T Arakawa, D Ejima, Y Kita, K Tsumoto - Biochimica et Biophysica Acta …, 2006 - Elsevier
A great deal of attention has been paid to so-called amyloid diseases, in which the proteins
responsible for the cell death and resultant diseases undergo conformational changes and …
responsible for the cell death and resultant diseases undergo conformational changes and …
Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications
YX Tao - Pharmacology & therapeutics, 2006 - Elsevier
Since the discovery of the first rhodopsin mutation that causes retinitis pigmentosa in 1990,
significant progresses have been made in elucidating the pathophysiology of diseases …
significant progresses have been made in elucidating the pathophysiology of diseases …
Mutational spectrum and genotype–phenotype correlations in mevalonate kinase deficiency
SHL Mandey, MS Schneiders, J Koster… - Human …, 2006 - Wiley Online Library
Mevalonate kinase deficiency (MKD) is an autosomal recessive autoinflammatory disorder
caused by mutations in the MVK gene resulting in deficient activity of mevalonate kinase …
caused by mutations in the MVK gene resulting in deficient activity of mevalonate kinase …
Chemical chaperones: mechanisms of action and potential use
E Papp, P Csermely - Molecular Chaperones in Health and Disease, 2006 - Springer
An increasing number of studies indicate that low-molecular-weight compounds can help
correct conformational diseases by inhibiting the aggregation or enable the mutant proteins …
correct conformational diseases by inhibiting the aggregation or enable the mutant proteins …
Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones
Y Wang, MC Bartlett, TW Loo, DM Clarke - Molecular pharmacology, 2006 - ASPET
Most mutants of the cystic fibrosis transmembrane conductance regulator (CFTR) that cause
severe symptoms of cystic fibrosis do not reach the cell surface because they are defective …
severe symptoms of cystic fibrosis do not reach the cell surface because they are defective …